Citation: Xiaolin Zhang, Xiuli Liu, Luhui Qin, Chao Tang, Yu Huo, Jinbin Wei, Ming Chen, Yutong Gao, Xiaoping Zhang, Yani Wu, Yongxiang Zhao, Renbin Huang, Liping Zhong, Bing Wang. Averrhoa carambola extractive inhibits breast cancer via regulating CEPT1 and LYPLA1[J]. Chinese Chemical Letters, ;2023, 34(3): 107618. doi: 10.1016/j.cclet.2022.06.041 shu

Averrhoa carambola extractive inhibits breast cancer via regulating CEPT1 and LYPLA1

Xiaolin Zhang ^{a, 1} ,
Xiuli Liu ^{b, 1} ,
Luhui Qin ^{a, 1} ,
Chao Tang ^{b, 1} ,
Yu Huo ^b ,
Jinbin Wei ^a ,
Ming Chen ^a ,
Yutong Gao ^a ,
Xiaoping Zhang ^a ,
Yani Wu ^a ,
Yongxiang Zhao ^b ,
Renbin Huang ^{a, *,} ,
Liping Zhong ^{b, *,} ,
Bing Wang ^{c, *,}

a.
Pharmaceutical College, Guangxi Medical University, Nanning 530021, China
b.
National Center for International Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Collaborative Innovation Center for Targeting Tumor Theranostics, Guangxi Medical University, Nanning 530021, China
c.
Department of Spine Surgery, The Second Xiangya Hospital of Central South University, Changsha 410011, China

huangrenbin518@163.com

zhong_liping@163.com

wbxyeyy@csu.edu.cn

Received Date: 3 March 2022
Revised Date: 14 June 2022
Accepted Date: 15 June 2022
Available Online: 19 June 2022

Figures(4)

Liposomes have been widely exploited as a drug delivery system in treating tumors because of their advantage to enhance anti-tumor efficacy and reduce side effects. In this study, the tumor-targeted 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione (DMDD, i.e., Averrhoa carambola extractive) liposomes (HA/TN-DLP) were conducted and assessed. HA/TN-DLP showed controllable drug loading (up to 83%) with high stability. In vitro and in vivo studies showed good cell uptake behavior and high inhibition rate of breast cancer compared to free DMDD. HA/TN-DLP might be the suitable for DMDD due to its better advantages in delivery, penetrability, and targeting-tumor capability. For in vivo mouse model tests, HA/TN-DLP effectively inhibited tumor growth compared to free DMDD. Further analyses indicated that HA/TN-DLP inhibited the glycerophospholipid metabolism pathway by reducing the biosynthesis of phosphatidylcholine and 1-acyl-sn-glycero-3-phosphocholine through regulating the expressions of CEPT1 and LYPLA1, and inhibited tumor cell growth by regulating the PI3K/Akt and NF-κB signaling pathways. In conclusion, the obviously enhanced antitumor effect further demonstrated that HA/TN-DLP may be a promising tumor-targeting agent.
- DMDD,
- Breast cancer,
- Transcriptomics,
- Metabolomics,
- PI3K/Akt pathway,
- Glycerophospholipid metabolism pathway
1. [1]
  X. Jiang, H. Tang, T. Chen, J. Gynecol. Oncol. 29 (2018) e7. doi: 10.3802/jgo.2018.29.e7
2. [2]
  J. Huang, X. You, P. Xin, et al., Chin. Chem. Lett. 32 (2021) 1737–1742. doi: 10.1016/j.cclet.2020.12.006
3. [3]
  X. Zhang, X. Duan, Y. Hu, et al., Nano Today 37 (2021) 101098. doi: 10.1016/j.nantod.2021.101098
4. [4]
  X. You, L. Wang, L. Wang, et al., Adv. Funct. Mater. 31 (2021) 2100805. doi: 10.1002/adfm.202100805
5. [5]
  A. Aruffo, I. Stamenkovic, M. Melnick, et al., Cell 61 (1990) 1303–1313. doi: 10.1016/0092-8674(90)90694-A
6. [6]
  L.Y. Bourguignon, H. Zhu, L. Shao, et al., J. Biol. Chem. 275 (2000) 1829–1838. doi: 10.1074/jbc.275.3.1829
7. [7]
  C. Li, X. You, X. Xu, et al., Adv. Sci. 9 (2022) e2104134. doi: 10.1002/advs.202104134
8. [8]
  J. Luo, C. Zhang, R. Liu, et al., J. Funct. Foods 47 (2018) 127–135. doi: 10.1016/j.jff.2018.05.041
9. [9]
  X. Zhou, X. Wu, L. Qin, et al., Drug Des. Dev. Ther. 14 (2020) 2667–2684. doi: 10.2147/dddt.s237699
10. [10]
  C. Chen, Z. Nong, Q. Xie, et al., Sci. Rep. 7 (2017) 6704. doi: 10.1038/s41598-017-07162-3
11. [11]
  Q. Wen, X. Lin, Y. Liu, et al., Molecules 17 (2012) 12330–12340. doi: 10.3390/molecules171012330
12. [12]
  M. Pons, M. Foradada, J. Estelrich, Int. J. Pharmaceut. 95 (1993) 51–56. doi: 10.1016/0378-5173(93)90389-W
13. [13]
  S. Yu, K. Zhu, J. Chen, et al., Nat. Commun. 9 (2018) 3369. doi: 10.1109/cac.2018.8623753
14. [14]
  T. Jiang, Z. Zhang, Y. Zhang, et al., Biomaterials 33 (2012) 9246–9258. doi: 10.1016/j.biomaterials.2012.09.027
15. [15]
  N. Yerushalmi, A. Arad, R. Margalit., Arch. Biochem. Biophys. 313 (1994) 267–273. doi: 10.1006/abbi.1994.1387
16. [16]
  J. Liu, Y. Sun, X. Liu, AAPS PharmSciTech 21 (2020) 259. doi: 10.1208/s12249-020-01792-z
17. [17]
  T. Sun, J. Gao, D. Han, Drug Deliv. 26 (2019) 975–988. doi: 10.1080/10717544.2019.1667454
18. [18]
  R.W. Johnstone, A.A. Ruefli, S.W. Lowe, Cell 108 (2002) 153–164. doi: 10.1016/S0092-8674(02)00625-6
19. [19]
  J.M. Adams, S. Cory, Science 281 (1998) 1322. doi: 10.1126/science.281.5381.1322
20. [20]
  R.B. Cornell, N.D. Ridgway, Prog. Lipid Res. 59 (2015) 147–171. doi: 10.1016/j.plipres.2015.07.001
21. [21]
  J.R. Krycer, L.J. Sharpe, W. Luu, et al., Trends Endocrinol. Metab. 21 (2010) 268–276. doi: 10.1016/j.tem.2010.01.001
22. [22]
  D.K. Nomura, B.F. Cravatt, Lipid Metab. Cancer FEBS J. 1831 (2013) 1497–1498. doi: 10.1016/j.bbalip.2013.08.001
23. [23]
  T.C. Knauss, F.E. Jaffer, H.E. Abboud, J. Biol. Chem. 265 (1990) 14457–14463. doi: 10.1016/S0021-9258(18)77324-9
24. [24]
  A. Norambuena, C. Metz, L. Vicuña, et al., J. Biol. Chem. 284 (2009) 12670–12679. doi: 10.1074/jbc.M808949200
25. [25]
  R.L.B. Costa, H. Han, W.J. Gradishar, Breast Cancer Res. Treat. 169 (2018) 397–406. doi: 10.1007/s10549-018-4697-y
26. [26]
  P. Rusquec, C. Blonz, J.S. Frenel, Ther. Adv. Med. Oncol. 12 (2020) 1758835920940939. doi: 10.1177/1758835920940939
27. [27]
  J.C. Coffey, J. Wang, M.J.F. Smith, et al., J. Biol. Chem. 280 (2005) 20968–20977. doi: 10.1074/jbc.M414696200
28. [28]
  X. Zhen, H. Choi, J. Kim, et al., Biomolecules 10 (2020) 245. doi: 10.3390/biom10020245
29. [29]
  Z. Orlova, F. Pruefer, R.C. Oropeza, et al., Biochim. Biophys. Acta Mol. Cell Res. 1866 (2019) 598–611. doi: 10.1016/j.bbamcr.2019.01.002
1. [1]
  Yue Xu , Lingzhi Wang , Liu Yang , Renliang Xue , Haowen Zhu , Qifeng Liu , Xueqi Lv , Ruiping Zhang , Jun Tu , Qingce Zang , Yinghong Wang . Spatial metabolomics combined with transcriptomics to reveal heterogeneous metabolism and drug response in the heart of rats with heart failure. Chinese Chemical Letters, 2025, 36(7): 110958-. doi: 10.1016/j.cclet.2025.110958
2. [2]
  Yanhua Chen , Xian Ding , Jun Zhou , Zhaoying Wang , Yunhai Bo , Ying Hu , Qingce Zang , Jing Xu , Ruiping Zhang , Jiuming He , Fen Yang , Zeper Abliz . Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters, 2025, 36(1): 110351-. doi: 10.1016/j.cclet.2024.110351
3. [3]
  Lijuan Liu , Zhihao Zhao , Feiwan Zou , Wukun Liu , Yunlong Lu . Advances in combination therapy for the treatment of estrogen receptor positive breast cancer. Chinese Chemical Letters, 2025, 36(10): 111451-. doi: 10.1016/j.cclet.2025.111451
4. [4]
  Xiaoxiao Wang , Bolun Wang , Fenfen Ji , Jie Yan , Jiacheng Fang , Doudou Zhang , Ji Xu , Jing Ji , Xinran Hao , Hemi Luan , Yanjun Hong , Shulan Qiu , Min Li , Zhu Yang , Wenlan Liu , Xiaodong Cai , Zongwei Cai . Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics. Chinese Chemical Letters, 2024, 35(11): 109653-. doi: 10.1016/j.cclet.2024.109653
5. [5]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
6. [6]
  Xinyue Han , Yunhan Yang , Jiayin Lu , Yuxiang Lin , Dongxue Zhang , Ling Lin , Liang Qiao . Efficient serum lipids profiling by TiO₂-dopamin-assisted MALDI-TOF MS for breast cancer detection. Chinese Chemical Letters, 2025, 36(5): 110183-. doi: 10.1016/j.cclet.2024.110183
7. [7]
  Lulu He , Le Wang , Zhen He , Yiqian Yang , Cheng Heng Pang , Aiguo Wu , Bencan Tang , Juan Li . An imine-linked covalent organic framework with intrinsic photo-induced mitochondrial regulation for breast cancer therapy. Chinese Chemical Letters, 2025, 36(9): 110717-. doi: 10.1016/j.cclet.2024.110717
8. [8]
  Xiongbo Song , Jinwen Xiao , Juan Wu , Li Sun , Long Chen . Decellularized amniotic membrane promotes the anti-inflammatory response of macrophages via PI3K/AKT/HIF-1α pathway. Chinese Chemical Letters, 2025, 36(1): 109844-. doi: 10.1016/j.cclet.2024.109844
9. [9]
  Xuyang Chai , Hiu-Lok Ngan , Yuanyuan Song , Zenghua Qi , Lifang Zhao , Wenqi Chen , Shanshan Chen , Zhenhua Yang , Ruijin Li , Chuan Dong , Zhu Yang , Zongwei Cai . Real-world PM_2.5 exposure induces prostaglandin disruption and low-density lipoprotein oxidation, exacerbating atherogenesis in ApoE^−/− mice. Chinese Chemical Letters, 2025, 36(9): 110671-. doi: 10.1016/j.cclet.2024.110671
10. [10]
  Qiongqiong Wan , Zhourui Zhang , Mengmeng Zhao , Xianqin Ruan , Yanhong Hao , Jiajun Deng , Yunlang She , Minglei Yang , Yongxiang Song , Feng Jin , Ailin Wei , Sheng Zhong , Jie Zheng , Dong Xie , Suming Chen . Efficient diagnosis of benign and malignant pulmonary nodules based on Nano-zero-valent iron enhanced serum metabolic fingerprinting. Chinese Chemical Letters, 2025, 36(10): 110794-. doi: 10.1016/j.cclet.2024.110794
11. [11]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
12. [12]
  Zimo Yang , Yan Tong , Yongbo Liu , Qianlong Liu , Zhihao Ni , Yuna He , Yu Rao . Developing selective PI3K degraders to modulate both kinase and non-kinase functions. Chinese Chemical Letters, 2024, 35(11): 109577-. doi: 10.1016/j.cclet.2024.109577
13. [13]
  Qian Wu , Yuanxia Lv , Zixuan Guo , Zhihao Zhao , Zhimin Zhang , Hongmei Lu . A Case Study and Practice of Research-Oriented Comprehensive Instrumental Analysis Laboratory Courses. University Chemistry, 2025, 40(10): 194-202. doi: 10.12461/PKU.DXHX202411063
14. [14]
  Jialin Xie , Qing Feng , Zhen Li , Jinyi Yang , Min Liu , Wei Qi . Life’s Guardian Angel: Progesterone. University Chemistry, 2024, 39(10): 416-419. doi: 10.12461/PKU.DXHX202403068
15. [15]
  Kunya Wang , Bingyu Liu , Daojiang Yan , Jian Bai , Haibo Yu , Youcai Hu . Full biosynthetic pathway of pyrrolobenzoxazines. Chinese Chemical Letters, 2025, 36(1): 109811-. doi: 10.1016/j.cclet.2024.109811
16. [16]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
17. [17]
  Honghao Sun , Huimin Zhao , Ronghui Yin , Chenxi Zhou , Ming Wu , Yueyang Deng , Zhanwei Zhou , Minjie Sun . Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases. Chinese Chemical Letters, 2025, 36(5): 110067-. doi: 10.1016/j.cclet.2024.110067
18. [18]
  Peng Gao , Yuanyuan Chen , Qianlin He , Xue Liu , Echuan Tan , Zhiqiang Yu , Hui Wang . Highly efficient adoptive cell therapy of metastatic triple negative breast cancer with bioactive covalent organic framework-engineered macrophages. Chinese Chemical Letters, 2025, 36(8): 110585-. doi: 10.1016/j.cclet.2024.110585
19. [19]
  Chao Liu , Liming Gong , Yanhong Liu , Shuangqing Wang , Hao Wu , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang . Lipoic acid-locked reduction-responsive core-cross-linked micelles delivering paclitaxel for triple-negative breast cancer treatment. Chinese Chemical Letters, 2025, 36(8): 110570-. doi: 10.1016/j.cclet.2024.110570
20. [20]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(1152)
HTML views(99)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142